Pokmon Card Boom Nostalgia Speculation and HighProfile Collectors Drive MultiMillion Dollar Market Yardeni Warns Fed May Need to Raise Rates in July to Pacify Bond Vigilantes Under Incoming Chair Warsh Dollar Holds Near SixWeek High as Middle East Tensions and Fed Uncertainty Weigh on Global Currencies Eicher Motors Q4 FY26 Net Profit Rises 12 YoY to Rs 1520 Crore Revenue Jumps 16 MidAmerica Apartment Communities MAA Faces Lower Rent Growth Outlook After Scotiabank Downgrade Dow Leads Gains as Consumer Stocks Rally Energy Slips Golden Entertainment Inc GDEN Q4 2025 Earnings Significant EPS Miss Amid Flat Revenue Disclosure Cantaloupe Inc CTLP Q1 2026 Earnings EPS Misses Estimates by 50 Guardian Pharmacy Services GRDN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement UFPI Q1 2026 Earnings Earnings Miss Estimate Amid Challenging Conditions HUBS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ARKO Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Enovis Corporation ENOV Faces Selling Pressure Near Resistance Support in Focus WW International Inc WW Surges Over 26 Analyzing the Breakout Move PowerBank Corporation SUUN Slips Marginally as Traders Eye Key Support at 098 Nuveen Arizona Quality Municipal Income Fund NAZ Holds Steady Near Support Amid Modest Decline Albany International AIN Holds Steady Near Support as Technical Picture Remains Mixed IDN Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat Houlihan Lokey Q1 2026 Earnings Earnings Miss Weighs on Shares as Advisory Volumes Remain Subdued ASB Q1 2026 Earnings Associated BancCorp Beats EPS Estimates Stock Edges Higher Tower Semiconductor Ltd TSEM Q1 2026 Earnings Robust EPS Beat Highlights Operational Discipline Amid Revenue Uncertainty Dyne Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Drives Slight Stock Uptick CVSA Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction Intuits Latest Earnings May Challenge Morgan Stanleys Stock Forecast FNGR Q4 2024 Earnings EPS Misses Estimates as Company Navigates Transition eXoZymes Inc EXOZ Climbs 313 as Biotech Stock Tests Key Resistance at 1074